Select Medical Holdings Corporation (NYSE:SEM) Receives $17.80 Consensus PT from Brokerages

Select Medical Holdings Corporation (NYSE:SEMGet Free Report) has been assigned an average rating of “Moderate Buy” from the six brokerages that are covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, one has given a hold rating and four have assigned a buy rating to the company. The average 1-year target price among analysts that have issued ratings on the stock in the last year is $17.80.

A number of analysts have issued reports on SEM shares. Benchmark reissued a “buy” rating on shares of Select Medical in a research report on Monday, October 27th. Royal Bank Of Canada lifted their price objective on Select Medical from $16.00 to $20.00 and gave the stock an “outperform” rating in a report on Wednesday, October 8th. Mizuho set a $17.00 price objective on shares of Select Medical in a report on Monday, November 3rd. Bank of America reduced their target price on shares of Select Medical from $18.00 to $15.00 and set a “buy” rating for the company in a research note on Wednesday, September 10th. Finally, Wall Street Zen upgraded shares of Select Medical from a “hold” rating to a “buy” rating in a research note on Saturday, November 8th.

Get Our Latest Stock Analysis on Select Medical

Select Medical Price Performance

SEM opened at $14.80 on Monday. Select Medical has a fifty-two week low of $11.65 and a fifty-two week high of $20.83. The firm has a 50-day moving average of $14.35 and a 200 day moving average of $13.85. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.09 and a current ratio of 1.09. The firm has a market cap of $1.83 billion, a P/E ratio of 17.20, a PEG ratio of 0.56 and a beta of 1.28.

Select Medical (NYSE:SEMGet Free Report) last released its earnings results on Thursday, October 30th. The health services provider reported $0.23 earnings per share for the quarter, beating analysts’ consensus estimates of $0.18 by $0.05. Select Medical had a net margin of 2.05% and a return on equity of 7.41%. The firm had revenue of $1.36 billion for the quarter, compared to analysts’ expectations of $1.33 billion. During the same period in the previous year, the company earned $0.43 earnings per share. The company’s quarterly revenue was up 7.2% on a year-over-year basis. Select Medical has set its FY 2025 guidance at 1.140-1.240 EPS. On average, research analysts expect that Select Medical will post 1.17 EPS for the current year.

Select Medical Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, November 25th. Stockholders of record on Wednesday, November 12th were issued a $0.0625 dividend. This represents a $0.25 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date of this dividend was Wednesday, November 12th. Select Medical’s dividend payout ratio (DPR) is presently 29.07%.

Institutional Trading of Select Medical

Institutional investors have recently added to or reduced their stakes in the stock. Tudor Investment Corp ET AL purchased a new position in Select Medical during the 3rd quarter valued at about $1,466,000. CIBC Bancorp USA Inc. bought a new position in shares of Select Medical in the third quarter valued at approximately $153,000. Wilmington Savings Fund Society FSB grew its stake in Select Medical by 20.9% during the third quarter. Wilmington Savings Fund Society FSB now owns 5,784 shares of the health services provider’s stock valued at $74,000 after acquiring an additional 999 shares in the last quarter. Woodline Partners LP bought a new stake in Select Medical during the 3rd quarter worth approximately $7,159,000. Finally, Voleon Capital Management LP purchased a new stake in Select Medical in the 3rd quarter worth approximately $1,092,000. Hedge funds and other institutional investors own 89.48% of the company’s stock.

Select Medical Company Profile

(Get Free Report)

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.

Further Reading

Analyst Recommendations for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.